Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06046118

Photobiomodulation in Dry Age Related Macular Degeneration

Outcomes of Photobiomodulation in DRy Age Related macUlar Degeneration: a proSpective multicEnter raNdomized Controlled (DRUSEN) Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate effects of consecutive Yellow and Red Light Emitting Diode photobiomodulation in dry age-related macular degeneration (AMD). The main questions it aims to answer are: * Is Yellow and Red Light Emitting Diode photobiomodulation effective in decreasing drusen volume in patients affected by dry AMD? * Does Yellow and Red Light Emitting Diode photobiomodulation increase visual acuity and contrast sensitivity in patients affected by dry AMD? Participants will be randomly assigned to a treatment or a sham group. Treatment consists in two cycles with two phases each: * 1st phase: 300 seconds of continuous Yellow light with eyes closed + 60 seconds of pulsed Yellow light with eyes opened; * 2d phase: 300 seconds of continuous Red light with eyes closed + 60 seconds of pulsed Red light with eyes opened. Cycle 1 consists of 8 sessions (two PBM per week for 4 weeks) and cycle 2 consists of 6 sessions (two PBM per week for 3 weeks). Researchers will compare patients in the treatment group to those in the sham group to evaluate differences in objective signs and subjective symptoms of dry AMD.

Conditions

Interventions

TypeNameDescription
DEVICEYellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)Each session consists of: * 1st phase: 300 seconds of continuous Yellow light (eyes closed) + 60 seconds of pulsed Yellow light (eyes opened) * 2nd phase: 300 seconds of continuous Red light(eyes closed) + 60 seconds of pulsed Red light (eyes opened). Cycle 1: 8 sessions (two PBM per week for 4 weeks); Cycle 2: 6 sessions (two PBM per week for 3 weeks).
DEVICESham MaskLow light emission mask (Sham Mask, Espansione group, Bologna, Italy)

Timeline

Start date
2023-04-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-09-21
Last updated
2024-09-19

Locations

7 sites across 4 countries: France, Italy, Turkey (Türkiye), United Kingdom

Source: ClinicalTrials.gov record NCT06046118. Inclusion in this directory is not an endorsement.